increased production at n carolina

Some extra detail of BTA announcement a while back.

This type of news, in my opinion, is the best news BTA can get.

''DelGiorno said GSK is investing $2 billion in flu medications over the next few years -- for research and development and expanding manufacturing capacity of flu vaccine and its flu treatment Relenza. That includes installing two new Relenza manufacturing lines at GSK's Zebulon plant and adding 70 temporary workers at the 1,100-employee plant.''


http://www.newsobserver.com/104/story/536790.html